This federal contract award, valued at $24,136.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty medication, to support military healthcare programs.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the U.S. military and veterans' healthcare systems globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
This particular contract award was not designated with a set-aside requirement, indicating open competition. The award demonstrates Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems, through its extensive supply chain and distribution capabilities.
Generated 3/17/25, 9:47 AM